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INTRODUCTION 
Vitamin D is involved in regulating the calcium 
homeostasis and exerts beneficial effects on skeletal 
health of the bones. Serum concentrations of 25-
hydroxyvitamin D (25[OH]D) are measured to assess 
vitamin D status, which is mainly determined by 
sunlight (ultraviolet-B [UV-B]) induced vitamin D 
production in the skin and, to a lesser extent, by dietary 
or supplemental vitamin D intake [1]. The Institution of 
Endocrinology Clinical Practice Guidelines pointed out 
that vitamin D deficiency was defined as a serum 25-
hydroxyvitamin D (25-OHD) content less than 20ng/mL 
(or 50nmol/L) [2]. 
The epidemic of vitamin D deficiency in India, 
irrespective of their age, gender, race is likely to 
significantly contribute to the increasing burden on the 
healthcare system. Traditional and social taboos often 
dictate lifestyle patterns such as clothing that may limit 
sun exposure and vegetarianism which certainly limits 
vitamin D abundant dietary options. Most Indians are 
vegetarians, and they are socioeconomically backward 
people constitute a large percentage of the population in 
India. The underprivileged generally suffer from overall 
poor nutrition.  
Vitamin D rich dietary sources are limited and 
unaffordable to most of the Indians. Vitamin D 
supplements are available, but most Indians are not 
aware that they need additional vitamin D. Additionally, 
the cost of these supplements is essentially prohibitive 
to the majority. Fortification of staple foods with 
vitamin D may prove to be a more viable solution 
towards attaining vitamin D sufficiency in India [3]. 
Vitamin D is endogenously synthesized in human 
beings from photoconversion of 7-dehydrocholesterol in 
the skin to cholecalciferol on exposure to ultraviolet 
radiation of sun. In a tropical country like India, where 
sunlight exposure is abundant, vitamin D deficiency 
seems unlikely. However, as opposed to this, various 
studies have highlighted that 70-100% Indians in 
different age groups vitamin D insufficient or deficient 
[4]. 
Comparing to commonly used capsules, tablets of oral 
dosage forms, the sublingual absorption is generally 
faster and more efficient. The percentage of each dose 
absorbed is generally higher than that achieved by oral 
ingestion. To reach a systemic circulation of 
administered sublingually is reached within 10-15 
minutes, which is much faster than when ingested orally 
[5].  
The aim of this paper is to impress upon the practicing 
physicians in India about the gravity of the vitamin D 
deficiency problem throughout India, so that they may 
take necessary caution and care in the diagnosis and 
treatment of vitamin D deficiency [4]. 
Objective: To study the age-wise distribution of the 
participants, estimation of serum vitamin D level before 
and after therapy of sublingual vitamin D3 drug. 
MATERIAL AND METHODOLOGY    
Study design: This was an Interventional study 
Ethics approval: The study was registered in the 
Clinical Trial Registry of India and the International 
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 clinical trial registry platform (CTRI/2017/03/008033). 
Informed consent was taken from the participants. 
Study location: The study was conducted in 
collaboration with the Department of Family and 
General Medicine in Pravara Rural hospital.  
Sample size: 200 Participants  
Inclusion criteria: Patients who had less than 20ng/ml 
of serum 25(OH)D level, patients between 18-60years, 
and of either sex.  
Exclusion criteria: Patients taking Vitamin D or 
Calcium supplements.  
Methodology: All volunteers fulfilling the Inclusion 
were given sublingual vitamin D3 tabulates in 6 doses 
for 3 months, one tablet (60,000 International Units) 
every 15 days of follow up. The subject’s serum 25(OH)
D levels were estimated at the baseline (Before taking 
into study) and after treatment (End the end of the 
study). There is no financial burden on patients because 
this is a sponsored project given by Director of 
Research (Pravara Institute of Health Sciences and 
Duram Pharmachem Private Limited (Mumbai). 
Statistical analysis: Wilcoxon matched-paired test was 
applied  
RESULTS  
Table 1: Age wise distribution of participants  
 
Table 2: Distribution of participants according to 
estimate of serum Vitamin D3 level 
 
Total number of participants in our study was 200 ,111 
males and 89 females, the mean age in our study was 
51.07 ± 7.39Yrs., patient with Minimum age was 26.0 
Yrs., and Maximum was 60 Yrs. (Table 1) 
Significant increase in serum vitamin D level was seen 
after sublingual vitamin D3 tablets treatment. (Table 2) 
Age Groups 
(Years) 
Gender   
Male Female Total 
≤ 30 00 02 02 
≥ 31- ≤ 40 15 11 26 
≥ 41 - ≤50 41 26 67 
≥ 51 - ≤60 55 50 105 
Total 111 89 200 
  
serum Vitamin D3 level  (ng/ml) 
Baseline 
visit 
At the end the 6th Fol-
low up visit 
Mean ±SD 16.61±6.71 35.80±7.80 
Median 15.60 36.00 
test 
Wilcoxon matched paired test 
P<0.0001 Significant 
DISCUSSION 
Currently, 25(OH)D levels below 20 ng/mL or 50 nmol/l, 
with resultant consistent increased of Parathyroid 
hormone and reduction in intestinal calcium absorption, 
are considered indicative of vitamin D deficiency [6,7]. 
Our results show age-wise distribution of the total number 
of participants (Table 1) were 200, 111 males and 89 
females, and this results accordance with Qureshi D et al. 
[8] and Ravinandana et al [9] male 45(73.4%), female 15
(26.6%). the mean age in this study was 51.07 ± 
7.39Years  this is compared to other research Flojaune et 
al study [10] mean age was 51.8±4.7 in our minimum 
study age was  26.0 years similar study Jessica Kendrick 
et al. [11] study was found 27 years, and Maximum age 
was - 60 Years  comparing another study Thomas Larsen 
et al. age was 60 years [12]. 
The reason for the possible difference in the pattern for 
young and old subjects is uncertain. The higher body 
mass index in the older group could have had an effect or 
possibly the liver 25-hydroxylase reached its maximum 
capacity earlier (that is at a lower precursor 
concentration) in the older subjects, thus blunting the 
induced rise in calcidiol. Some other explanations must be 
sought for the slower rate of decline in the older subjects. 
Metabolic consumption appears to be slower. By itself, 
this would have been predicted to lead not only to a 
slower clearance but to a higher initial concentration as 
well. so, there is seemingly a need to invoke two 
differences in the handling of vitamin D between the 
younger and older ages [13]. 
Estimated of serum 25(OH)D level according to the 
participants (Table number : 02) at  the baseline it was 
16.61±6.71 ng/ml, a significant increase in serum vitamin 
D level was seen after sublingual vitamin D3 tablets 
treatment it was increased to 35.80 ±7.80 ng/ml, this 
result supported to the  Vitamin D sufficiency is defined 
in terms of the serum level of the prohormone 25(OH)D 
required for bone health, which is 30 to 32 ng/ml, it 
maintenance of a 30 to 32 ng/mL serum level requires 
approximately 2,200 to 3,000 IU/d of vitamin D from all 
sources, including ultraviolet light exposure, food, and 
supplements [14-16]. 
Marium et al studied-on effect of oral Vitamin D in the 
dose of 60000IU every Two monthly for four months. 
The mean serum vitamin D before treatment was 
27.1±7.7ng/mL, which increased to 42.0±9.1ng/mL, there 
was a statistically significant increase in serum Vitamin D 
levels after treatment [13]. A sixteen weeks of study Ryan 
et al., Vitamin D deficient patients were treated with oral 
Vitamin D 2000IU daily for three months. There was 
statistically significant and increased mean serum 
Vitamin D level from 34.3±2.2 to 100.9±6.6ng/mL [17]. 
Davide et al studied the effect of oral Vitamin D 2800ID 
daily dose on hypertensive patients after a period of two 
months. The mean serum vitamin D levels before 
treatment was 18.3±2.8ng/ml, which increased to 
38.4±3.2ng/ml, which was statistically significant [18]. 
Similarly, W.R. Chen et al. observed a statistically 
significant increase in mean serum vitamin D levels from 
19.4 ±11.6 to 34.1 ±12.2.3ng/ml after treatment with 
Vitamin D 2000IU daily for six months [19]. 
A one month of study Anand Vaidya et al studied in 
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 Vitamin D deficient patients were treated with oral 
Vitamin D3 15,000 IU daily. There was statistically 
significant increase in mean serum Vitamin D from 
16.55± 1.93to 51.9± 3.1 ng/ml [20]. 
Miles D. Witham et al randomized clinical trial 
observed in serum 25(OH) D levels increased from at 
the baseline level of 18 to 28 ng/ml after treatment of 
100000 U of oral cholecalciferol every 3 months for one 
year [21].  Above the all the studies vitamin D was 
administered orally daily was given for longer duration 
whereas, in our study sublingual vitamin D3, 60,000 
International Units was given every  15 days here the 
results are showing the increased  serum vitamin D level 
might be the sublingual route of administration of 
vitamin D3 is the novelty of our study. 
CONCLUSION 
The sublingual route of vitamin D3 therapy showed the 
increase of serum vitamin D levels significantly in 
Vitamin D deficiency patients. 
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